StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Motilal Oswal

BUYSun Pharmaceutical Industries Ltd.

byMotilal OswalHorizon: NA (inferred 1 year)31 Jul 2025via Institutional / Brokerage Research

Entry₹1,706.7Inferred
Target₹1,960
Total upside +14.84% (call closed)
Stop lossNot given
Exit₹1,96015 Jul 2026, 12:07 pm
Target hit+14.84%0.00%upside left
Follow Motilal Oswal for new calls(61% target hit, 1112 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 14 active Long-term calls on SUNPHARMA

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 15 Jul 2026
5 supporting3 neutral0 opposing
Supports the BUY call (5)

Sun Pharmaceutical Industries Limited has received approval to manufacture and market a generic version of semaglutide in South Africa, expanding its product portfolio and market access.

NSE · Press Release·15 Jul · today

(opens in new tab)

Sun Pharma has entered into an agreement to acquire 100% outstanding shares of Innovcare Lifesciences Private Limited for approximately Rs 271.2 Crores. Innovcare is engaged in marketing, distribution

BSE · Company Update·20 Jun · 3w ago

(opens in new tab)

3 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·28 Apr · 3mo ago

Neutral / worth noting (3)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.